Gaudard P, Mourad M, Eliet J, Zeroual N, Culas G, RouviÃ¨re P, et al
. Management and outcome of patients supported with Impella 5.0 for refractory cardiogenic shock. Crit Care. 2015;19:363 pubmed publisher
..1 (1.2-14.2); p = 0.02). Impella 5.0 allowed fast weaning of inotropes and might facilitate myocardial recovery. Despite high severity scores at admission, day-28 mortality rate was better than predicated. ..
Colson P, Virsolvy A, Gaudard P, Charrabi A, Corbani M, Manière M, et al
. Terlipressin, a vasoactive prodrug recommended in hepatorenal syndrome, is an agonist of human V1, V2 and V1B receptors: Implications for its safety profile. Pharmacol Res. 2016;113:257-264 pubmed publisher
..Terlipressin is a non-selective vasopressin analogue, exhibiting intrinsic agonist properties. Its full V2 receptor agonism may result in renal effects potentially aggravating water retention and hyponatremia of cirrhosis. ..